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ABSTRACT 
Studies conducted on Genetic Hypercalciuric-Stone Forming (GHS) rats have shown that 
their excess calcium urine excretion might be caused by significantly high vitamin D receptor 
(VDR) levels found in key calcium-transporting tissues, since high VDR raises physiological 
response to 1,25(OH)2D3, the hormonally active metabolite of vitamin D that regulates calcium 
levels in the body. We suggest that the high VDR levels in GHS tissue are a result of altered 
post-translational modification by ubiquitin and Small Ubiquitin-like Modifier (SUMO), which 
regulate the degradation of nuclear proteins substrates such as VDR.  
Our inquiry begins by overexpressing ubiquitin, SUMO-1, SUMO-2, and SUMO-3 in rat 
tissue to perform targeted gene expression of VDR. Western blot will be used to analyze 
resulting changes in the VDR signaling pathway and the degree to which the GHS rat phenotype 
is emulated with the added ubiquitin or SUMO. Our proceeding step will be to measure changes 
in VDR levels after performing an siRNA-facilitated knockdown of the E1, E2, and E3 enzymes 
that facilitate ubiquitination of nuclear proteins. Our final experiment will consist of isolating 
proteins from GHS bone marrow, intestinal, and renal cells and recording ubiquitin levels to 
compare with control tissue. 
If there is a consistent trend in the ubiquitin levels of GHS cells compared to control 
cells, and the western blot and enzyme knockdown procedures reveal that altered 
ubiquitin/SUMO presence affects VDR levels, then there will be evidence to show that the 
general hypercalciuiric phenotype could be an eventual result of insufficient VDR degradation 
due to abnormal post-translational protein modification. 
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